This study evaluates how women feel about using DNA from a vaginal fluid collection for early detection of endometrial cancer.

Inclusion Criteria:

• Self-identified Black individuals ≥ 45 years with an intact uterus
• Assigned female sex at birth
• Experience with abnormal uterine or post-menopausal bleeding (defined as vaginal bleeding between periods, heavy vaginal bleeding, vaginal bleeding after menopause, and/or red, brown, or pink colored vaginal discharge after menopause)
• Willing to participate in a 45-minute virtual interview

Exclusion Criteria:

• Previous or current diagnosis of endometrial cancer

Self-identified Black females 45 years or older with an intact uterus recruited through Mayo Clinic in Rochester